Surgery Websites
Surgical Innovations »  People »  Faculty Directors »  Shuvo Roy, Ph.D.

Shuvo Roy, Ph.D.

Professor, Departments of Bioengineering & Therapeutic Sciences and Surgery
UCSF Schools of Pharmacy and Medicine
Engineering Lead, Surgical Innovations Program
Director, Biodesign Laboratory
UCSF Faculty Director, UC Berkeley-UCSF Master of Translational Medicine (MTM) Program
Technical Director, The Kidney Project

Contact Information

1700 4th Street
San Francisco CA 94158
Phone 415-514-9666
Open Popup

PhD, Electrical Engineering and Applied Physics, Case Western Reserve University, 2001
MS, Electrical Engineering and Applied Physics, Case Western Reserve University, 1995
BS, Physics, Mathematics, and Computer Science, Mount Union College, Alliance, Ohio, 1992

  • UCSF - UC Berkeley Joint Graduate Group in Bioengineering
  • Pharmaceutical Sciences and Pharmacogenomics Graduate Program (PSPG)
  • UC Berkeley - UCSF Master of Translational Medicine (MTM) Program California Institute for Quantitative Biosciences (QB3)
  • Artificial Kidney
  • Artificial Organs
  • Biocompatibility
  • Bioengineering
  • BioMEMS
  • Medical Devices
  • Microelectromechanical Systems
  • Microtextured Substrates
  • Nanotechnology
  • Renal Replacement
  • Sensors
  • Therapeutics
  • Tissue Engineering
  • Transducers

Shuvo Roy, PhD, is a bioengineer focusing on the development of medical devices to address unmet clinical needs through strong collaboration and a multidisciplinary approach.

Dr. Roy is a professor at the University of California, San Francisco in the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the UCSF Schools of Pharmacy and Medicine, and is a faculty affiliate of the California Institute for Quantitative Biosciences (QB3). He is the director of the Biodesign Laboratory located on the Mission Bay campus. In addition, he serves as the Technical Director of The Kidney Project and is a founding member of the UCSF Pediatric Device Consortium. He has developed and currently teaches a course on medical devices, diagnostics, and therapeutics and regularly lectures on the medical device design process to UCSF graduate students and to national and international academic and industry audiences. He is the author of more than 100 publications and co-author of three book chapters, and holds multiple patents for device developments.

Before joining UCSF in 2008, Roy co-directed the BioMEMS Laboratory in the Department of Biomedical Engineering at Cleveland Clinic in Cleveland, Ohio, focusing on clinical applications of MEMS. In 1992 he earned a BS degree, magna cum laude, for triple majors in physics, mathematics, and computer science, from Mount Union College in Alliance, Ohio. In 1995, he earned an MS in electrical engineering and applied physics and, in 2001, he earned a PhD in electrical engineering and computer science, both from Case Western Reserve University in Cleveland, Ohio.

He is the recipient of a Top 40 under 40 award by Crain's Cleveland Business in 1999 and the Clinical Translation Award at the 2nd Annual BioMEMS and Biomedical Nanotechnology World 2001 meeting. In 2003, Dr. Roy was selected as a recipient of the TR100, which features the world's 100 Top Young Innovators as selected by Technology Review, the Massachusetts Institute of Technology's Magazine of Innovation. In 2004, he was presented with a NASA Group Achievement Award for his work on harsh environment MEMS. 

In 2005, Dr. Roy was named as a Who's Who in Biotechnology by Crain's Cleveland Business. In 2005 and 2007, he was recognized as a Cleveland Clinic Innovator. In 2009, he was nominated for the Biotechnology Industry Organization's Biotech Humanitarian Award, which is given in recognition of an individual who has used biotechnology to unlock its potential to improve the earth. 

In 2012, he was presented the Rising Star Award by BayBio Pantheon, and in that same year, he received the Innovation Pathway 2.0 Award from the Food and Drug Administration (FDA). Most recently, he was recognized as a Fellow by the Applied Innovation Institute in 2013.

Related Links

An Implantable Artificial Kidney: Interview with UCSF's Dr. Shuvo Roy

Improving Health By Our Own Devices (November 26, 2012)

Artificial Kidney Project at UCSF Receives $3 Million in New Funding (October 1, 2012)

New Technology to Improve Patient Care Highlighted at Dreamforce 2012 (September 24, 2012)

Health Care Game Changers to Address Dreamforce Conference (September 5, 2012)

Web-Enabled Bathroom Scale Could Monitor Heart Failure from Home (August 7, 2012)

UCSF Artificial Kidney Project Tapped for Accelerated FDA Program (April 9, 2012)

UCSF Consortium Collaborates to Invent Medical Devices for Children (November 1, 2011)

QB3 Signs Agreement to Accelerate Innovation (October 26, 2011)

Applied Innovation Institute
Requested Nominator
Heinz Awards
Rising Star Award
BayBio Pantheon
Innovation Pathway 2.0 Award
Food and Drug Administration (FDA)
UCSF Outstanding Faculty Mentorship Award, Finalist
University of California, San Francisco
mHealth Alliance Award
Vodafone Americas Foundation
Images of the Year Selection
Biomaterials Journal
Biotech Humanitarian Award Finalist
Biotechnology Industry Organization
Thomas G. Orr Memorial Lectureship
Southwestern Surgical Congress
Cleveland Clinic Innovator Award
Cleveland Clinic
Mentor Recognition Award
Cleveland Clinic Science Internship Program
Cleveland Clinic Innovator Award
Cleveland Clinic
Who's Who in Biotechnology
Crain's Cleveland Business
Ribbon Award, Outstanding Symposium Paper, MRS Fall Meeting
Materials Research Society
NASA Group Achievement Award, Harsh Environment MEMS
MIT TR100 Award, Top 100 Young Innovators
Technology Review Magazine
Clinical Translation Award
BioMEMS and Biomedical Nanotechnology World Meeting
Top 40 Under 40
Crain's Cleveland Business
Ruth Barber Moon Graduate Student Award
Case Western Reserve University
Senior Physics Prize
Mount Union College
William and Burdella Carl Mathematics Award
Mount Union College

Chronic kidney failure threatens about half a million people in the U.S. alone. Donated kidneys can restore health, but they are in are in short supply.  As a result, some 350,000 people with failing kidneys are tethered to dialysis machines several days a week – a tiring, uncomfortable and expensive treatment, and one that falls far short of performing a normal kidney's functions. Shuvo Roy, a professor in the UCSF Department of Bioengineering and Therapeutic Sciences, and his colleagues are developing an implantable, fully functional artificial kidney.  

Research projects include:

  • Development of an artificial kidney
  • Development of an intravascular bioreactor for islet therapy in Type 1 diabetes patients
  • Investigation into covalent attachment of self-assembled monolayer films to enhance biocompatibility of implanted devices
  • Resorbable electronics for tissue monitoring and stimulation, and dataloggers for patient monitoring
  • Development of compact hemofilters for renal replacement therapy
  • Wireless sensing systems for load measurement
  • Focused ultrasound transducers for minimally invasive imaging and therapy
Data provided by UCSF Profiles, powered by CTSI
  • Biodevice Innovation Training Program
    Sponsor ID:
    Funding Period:
    May 2017
    Apr 2022
    Co-Principal Investigator
  • Implantable Bio-Artificial Pancreas (iBAP)
    Sponsor ID:
    Funding Period:
    Sep 2017
    Jun 2020
    Principal Investigator
  • Building an Implantable Artificial Kidney
    Sponsor ID:
    Funding Period:
    Sep 2015
    Jun 2019
    Principal Investigator
  • Biocompatibility of Implantable Renal Replacement Devices
    Sponsor ID:
    Funding Period:
    May 2012
    Apr 2016
    Principal Investigator
  • Miniaturized Implantable Renal Assist Device for Total Renal Replacement Therapy
    Sponsor ID:
    Funding Period:
    Sep 2007
    Aug 2011
    Principal Investigator
  • Microneedle Array for Catheter Drug Delivery
    Sponsor ID:
    Funding Period:
    Sep 2003
    Aug 2006
    Principal Investigator
Data provided by UCSF Profiles, powered by CTSI
Data provided by UCSF Profiles, powered by CTSI
  1. Blauvelt DG, Abada EN, Oishi P, Roy S. Advances in extracorporeal membrane oxygenator design for artificial placenta technology. Artif Organs. 2020 Sep 26. View in PubMed
  2. Love H, Evans R, Humes HD, Roy S, Zent R, Harris R, Wilson M, Fissell WH. Metformin and Inhibition of Transforming Growth Factor-Beta Stimulate In Vitro Transport in Primary Renal Tubule Cells. Tissue Eng Part A. 2020 Oct; 26(19-20):1091-1098. View in PubMed
  3. Hojs N, Fissell WH, Roy S. Ambulatory Hemodialysis-Technology Landscape and Potential for Patient-Centered Treatment. Clin J Am Soc Nephrol. 2020 01 07; 15(1):152-159. View in PubMed
  4. Yee C, McCoy D, Yu J, Losey A, Jordan C, Moore T, Stillson C, Oh HJ, Kilbride B, Roy S, Patel A, Wilson MW, Hetts SW. Endovascular Ion Exchange Chemofiltration Device Reduces Off-Target Doxorubicin Exposure in a Hepatic Intra-arterial Chemotherapy Model. Radiol Imaging Cancer. 2019 Sep 27; 1(1):e190009. View in PubMed
  5. Wilson MH, Veach RA, Luo W, Welch RC, Roy S, Fissell WH. Genome Engineering Renal Epithelial Cells for Enhanced Volume Transport Function. Cell Mol Bioeng. 2020 Feb; 13(1):17-26. View in PubMed
  6. View All Publications


Site Directory